Insights into Editorial: Biosimilars need huge investments, longer timelines
Insights into Editorial: Biosimilars need huge investments, longer timelines What are Biosimilars? A biosimilar is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products and can be manufactured when the original product’s …
Continue reading “Insights into Editorial: Biosimilars need huge investments, longer timelines”
